Global Sti And Vaginitis Pcr Testing Market Size & Outlook
Global sti and vaginitis pcr testing market, 2018-2030 (US$M)
Related Markets
Global sti and vaginitis pcr testing market highlights
- The global sti and vaginitis pcr testing market generated a revenue of USD 661.0 million in 2024 and is expected to reach USD 1,111.9 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 9.2% by 2030.
- In terms of segment, sexually transmitted infections (stis) accounted for a revenue of USD 473.4 million in 2024.
- Vaginal Infections is the most lucrative condition segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Peru is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 661.0 million |
| Market revenue in 2030 | USD 1,111.9 million |
| Growth rate | 9.2% (CAGR from 2025 to 2030) |
| Largest segment | Sexually transmitted infections (stis) |
| Fastest growing segment | Vaginal Infections |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sexually Transmitted Infections (STIs), Vaginal Infections |
Other key industry trends
- In terms of revenue, the North America accounted for 43.0% of the global sti and vaginitis pcr testing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Peru is the fastest growing regional market and is projected to reach USD 4.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
STI And Vaginitis PCR Testing Market Scope
STI And Vaginitis PCR Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sansure Biotech | View profile | 1001-5000 | Changsha, Jiangsu, China, Asia | http://www.sansure.com.cn/ |
| BioFire Diagnostics | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | http://www.biofiredx.com |
| Abbott | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Certest Biotec | View profile | - | Zaragoza, Aragon, Spain, Europe | http://www.certest.es/ |
| Seegene | View profile | 51-100 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | http://www.seegene.com/ |
| Rentschler Biopharma SE | View profile | 501-1000 | Laupheim, Baden-Wurttemberg, Germany, Europe | https://www.rentschler-biopharma.com |
| altona Diagnostics GmbH | View profile | 101-250 | Hamburg, Hamburg, Germany, Europe | http://altona-diagnostics.com/en/ |
| Diasorin SpA | View profile | 3233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | https://www.diasoringroup.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
Global sti and vaginitis pcr testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sti and vaginitis pcr testing market will help companies and investors design strategic landscapes.
Sexually transmitted infections (stis) was the largest segment with a revenue share of 71.62% in 2024. Horizon Databook has segmented the Global sti and vaginitis pcr testing market based on sexually transmitted infections (stis), vaginal infections covering the revenue growth of each sub-segment from 2018 to 2030.
- Global STI And Vaginitis PCR Testing Condition Outlook (Revenue, USD Million, 2018-2030)
- Sexually Transmitted Infections (STIs)
- Chlamydia
- Gonorrhea
- Trichomoniasis
- Herpes Simplex Virus (HSV-1 & HSV-2)
- Human Papillomavirus (HPV)
- Syphilis
- Other
- Vaginal Infections
- Bacterial Vaginosis
- Vulvovaginal Candidiasis
- Other
- Sexually Transmitted Infections (STIs)
- Global STI And Vaginitis PCR Testing Test Type Outlook (Revenue, USD Million, 2018-2030)
- STI PCR Panels
- Vaginitis PCR Panels
- Global STI And Vaginitis PCR Testing End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals and Clinics
- Diagnostic Laboratories
- Homecare/At-home Testing
- Others
Reasons to subscribe to Global sti and vaginitis pcr testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global sti and vaginitis pcr testing market databook
-
Our clientele includes a mix of sti and vaginitis pcr testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global sti and vaginitis pcr testing market , including forecasts for subscribers. This global databook contains high-level insights into Global sti and vaginitis pcr testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global sti and vaginitis pcr testing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Sti and vaginitis pcr testing market size, 2024 (US$M)
Global sti and vaginitis pcr testing market share, by condition, 2024 & 2030 (%, US$M)
Sti and vaginitis pcr testing market: Opportunity assessment by country
Global sti and vaginitis pcr testing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
